[
1. SIEGEL R, MA J, ZOU Z, JEMAL A. Cancer statistics. CA Cancer J Clin. 2014; 64:9–29.10.3322/caac.2120824399786
]Search in Google Scholar
[
2. RAWLA P, SUNKARA T, GADUPUTI V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10–27.10.14740/wjon1166639677530834048
]Search in Google Scholar
[
3. ZABRON A, EDWARDS RJ, KHAN SA. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Dis Model Mech. 2013;6(2):281–292.10.1242/dmm.010561359701123520144
]Search in Google Scholar
[
4. GOUMA DJ, VAN GEENEN R, VAN GULIK T, DE WIT LT, OBERTOP H. Surgical palliative treatment in bilio-pancreatic malignancy. Ann Oncol. 1999;10 Suppl 4:269–272.10.1023/A:1008328802484
]Search in Google Scholar
[
5. AMERICAN CANCER SOCIETY. Survival rates for bile duct cancer [online]. 2019 https://www.cancer.org/cancer/bile-duct-cancer/detection-diagnosisstaging/survival-by-stage.html.
]Search in Google Scholar
[
6. KIRSTEIN MM, VOGEL A. Epidemiology and Risk Factors of Cholangiocarcinoma [published correction appears in Visc Med. 2017 Jun;33(3):226]. Visc Med. 2016;32(6):395–400.10.1159/000453013529044628229073
]Search in Google Scholar
[
7. HUANG L, JANSEN L, BALAVARCA Y, BABAEI M, VAN DER GEEST L, LEMMENS V, et al. Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study. BMC Med. 2018;16(1):125.10.1186/s12916-018-1120-9610280430126408
]Search in Google Scholar
[
8. MIHALACHE F, TANTAU M, DIACONU B, ACALOVSCHI M. Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period. J Gastrointestin Liver Dis. 2010;19(3):285–290.
]Search in Google Scholar
[
9. KAASSIS M, BOYER J, DUMAS R, PONCHON T, COUMAROS D, DELCENSERIE R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003;57(2): 178–182.10.1067/mge.2003.6612556780
]Search in Google Scholar
[
10. LA VECCHIA C, ROTA M, MALVEZZI M, NEGRI E. Potential for improvement in cancer management: reducing mortality in the European Union. Oncologist. 2015;20(5):495–498.10.1634/theoncologist.2015-0011442539425888268
]Search in Google Scholar
[
11. Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(8):1028–1061.10.6004/jnccn.2017.013128784865
]Search in Google Scholar
[
12. BENSON AB 3RD, ABRAMS TA, BEN-JOSEF E, BLOOMSTON MP, BOTHA JF, CLARY BM, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009;7(4):350–391.10.6004/jnccn.2009.0027446114719406039
]Search in Google Scholar
[
13. CONILL C, VERGER E, SALAMERO M. Performance status assessment in cancer patients. Cancer. 1990;65(8):1864–1866.10.1002/1097-0142(19900415)65:8<1864::AID-CNCR2820650832>3.0.CO;2-U
]Search in Google Scholar
[
14. VALERO V 3RD, COSGROVE D, HERMAN JM, PAWLIK TM. Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol. 2012;6(4):481–495.10.1586/egh.12.20
]Search in Google Scholar
[
15. HOFMARCHER T, LINDGREN P, WILKING N, JÖNSSON B. The cost of cancer in Europe 2018. European Journal of Cancer 129:41–49.10.1016/j.ejca.2020.01.011
]Search in Google Scholar
[
16. GAŃCZAK M, MIAZGOWSKI T, KOŻYBSKA M, KOTWAS A, KORZEŃ M, RUDNICKI B, et al. Changes in disease burden in Poland between 1990–2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017. PLoS One. 2020 Mar 2;15(3):e022676610.1371/journal.pone.0226766
]Search in Google Scholar
[
17. CHARI ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34(4):284–294.10.1053/j.seminoncol.2007.05.005
]Search in Google Scholar
[
18. PIANO M, BLACK G, AMELUNG D, POWER E, WHITAKER KL. Exploring public attitudes towards the new Faster Diagnosis Standard for cancer: a focus group study with the UK public. Br J Gen Pract. 2019;69(683):e413–e421.10.3399/bjgp19X702677
]Search in Google Scholar
[
19. KHAN SA, DAVIDSON BR, GOLDIN R, PEREIRA SP, ROSENBERG WMC, TAYLOR-ROBINSON SD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51 Suppl 6(Suppl 6):VI1–VI9.10.1136/gut.51.suppl_6.vi1
]Search in Google Scholar
[
20. JEMAL A, MURRAY T, WARD E, SAMUELS A, TIWARI RC, GHAFOOR A, et al. Cancer statistics, 2005 [published correction appears in CA Cancer J Clin. 2005 Jul-Aug;55(4):259]. CA Cancer J Clin. 2005;55(1):10–30.10.3322/canjclin.55.1.10
]Search in Google Scholar
[
21. VINCENT A, HERMAN J, SCHULICK R, HRUBAN RH, GOGGINS M. Pancreatic cancer. Lancet. 2011;378(9791): 607–620.10.1016/S0140-6736(10)62307-0
]Search in Google Scholar
[
22. SCHEITHAUER W, PUTORA PM, GRÜNBERGER B, EISTERER W, WÖLL E, PRAGER G, et al. Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine [published correction appears in Therap Adv Gastroenterol. 2019 Sep 23;12:175628481987763510.1177/1756284819877635
]Search in Google Scholar
[
23. PEIXOTO RD, RENOUF D, LIM H. A population based analysis of prognostic factors in advanced biliary tract cancer. J Gastrointest Oncol. 2014;5(6):428–432.
]Search in Google Scholar
[
24. HUIBREGTSE K, CARR-LOCKE DL, CREMER M, DOMSCHKE W, FOCKENS P, FOERSTER E, et al. Biliary stent occlusion-a problem solved with self-expanding metal stents? European Wallstent Study Group. Endoscopy. 1992;24(5): 391–394.10.1055/s-2007-10105051505486
]Search in Google Scholar
[
25. KNYRIM K, WAGNER HJ, PAUSCH J, VAKIL N. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy. 1993;25(3):207–212.10.1055/s-2007-10102948519239
]Search in Google Scholar
[
26. MOY BT, BIRK JW. An Update to Hepatobiliary Stents. J Clin Transl Hepatol. 2015;3(1):67–77.10.14218/JCTH.2015.00040454208126357636
]Search in Google Scholar
[
27. SCHMIDT M, SCHMIDT SAJ, ADELBORG K, SUNDBØLL J, LAUGESEN K, EHRENSTEIN V, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563-591.10.2147/CLEP.S179083663426731372058
]Search in Google Scholar
[
28. HIRIPI, E., GONDOS, A., EMRICH, K., HOLLECZEK, B., KATALINIC, A., LUTTMANN, S. Survival from common and rare cancers in Germany in the early 21st century. Annals of Oncology 2011; 23(2):472–479.10.1093/annonc/mdr13121597096
]Search in Google Scholar
[
29. DEYO D, KHALIQ A, MITCHELL D, HUGHES DR. Electronic sharing of diagnostic information and patient outcomes. Am J Manag Care. 2018;24(1):32–37
]Search in Google Scholar
[
30. KRUSE CS, KRISTOF C, JONES B, MITCHELL E, MARTINEZ A. Barriers to Electronic Health Record Adoption: a Systematic Literature Review. J Med Syst. 2016 Dec;40(12):252.10.1007/s10916-016-0628-9505404327714560
]Search in Google Scholar
[
31. GAVIN DR, VALORI RM, ANDERSON JT, DONNELLY MT, WILLIAMS JG, SWARBRICK ET. The national colonoscopy audit: a nationwide assessment of the quality and safety of colonoscopy in the UK. Gut. 2013;62(2):242–9.10.1136/gutjnl-2011-30184822661458
]Search in Google Scholar